<?xml version="1.0" encoding="UTF-8"?>
<ref id="B110-molecules-25-03846">
 <label>110.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Grisham</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ky</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Tewari</surname>
    <given-names>K.S.</given-names>
   </name>
   <name>
    <surname>Chaplin</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Walker</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Clinical trial experience with CA4P anticancer therapy: Focus on efficacy, cardiovascular adverse events, and hypertension management</article-title>
  <source>Gynecol. Oncol. Res. Pract.</source>
  <year>2018</year>
  <volume>5</volume>
  <pub-id pub-id-type="doi">10.1186/s40661-017-0058-5</pub-id>
 </element-citation>
</ref>
